https://clinicaltrials.gov/ct2/show/NCT02195349
The above link is regarding the GSK phase1 trial of our lag3 product. The above was released in December ‘17.
It’s fully recruited and to me it looks like the trial ends in March this year.
Interesting thing here is that the new CEO of GSK ordered a cul of products under trial last year , but our product in phase1 survived the cul.
Must have shown positive progress .
- Forums
- ASX - By Stock
- IMM
- O/N Nasdaq
O/N Nasdaq, page-190
-
- There are more pages in this discussion • 440 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.005(1.39%) |
Mkt cap ! $530.2M |
Open | High | Low | Value | Volume |
36.0¢ | 37.0¢ | 36.0¢ | $445.1K | 1.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 170533 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 456242 | 40 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 170453 | 0.365 |
19 | 228398 | 0.360 |
13 | 134773 | 0.355 |
16 | 218444 | 0.350 |
12 | 102362 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 454424 | 39 |
0.375 | 418916 | 11 |
0.380 | 154925 | 13 |
0.385 | 114722 | 9 |
0.390 | 209394 | 6 |
Last trade - 14.00pm 22/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online